What Most People Miss About Medicare Open Enrollment And The 2027 Shifts

What Most People Miss About Medicare Open Enrollment And The 2027 Shifts

Medicare open enrollment is happening right now, and sitting on autopilot could cost you real money in 2027. You have until December 7 to review your options, compare plans, and lock in changes that kick in on January 1. Even if you love your current coverage, the rules and price tags around it aren't staying put.

Honestly, most folks treat open enrollment like a chore they can skip whenever their mail looks familiar. That habit is risky this year. Between rising Part D caps and deductibles, shifting Medicare Advantage networks, and a fresh wave of negotiated drug prices arriving in 2027, your plan might look very different next winter.

Why Medicare Open Enrollment Matters More Right Now

Medicare open enrollment runs from October 15 through December 7 every year, giving people on Medicare a window to switch between Original Medicare and Medicare Advantage, jump to a different Medicare Advantage plan, or change Part D prescription drug coverage. Miss the December 7 deadline, and unless you qualify for a special enrollment period, you're largely stuck with your current setup for most of 2027.

Inflation and healthcare cost pressures have made shopping around less optional than usual. According to coverage analyses highlighted by AARP and KFF, millions of beneficiaries face plan exits, benefit adjustments, or fewer plan choices heading into 2027. When insurers pull back from specific counties or trim extras, assuming "my plan automatically renews" is basically a gamble.

A common mistake I see people make is judging a plan solely by its monthly sticker price. A low or zero-dollar monthly premium can hide a higher deductible, tighter doctor network, or pricier tiers for the exact prescriptions you take every month. Look at the whole year of spending, not just the bill that shows up in January.

The Biggest Medicare Shifts Arriving in 2027

Several major cost and coverage adjustments take effect on January 1, 2027, spanning Part A, Part B, Part D, and Medicare Advantage. Some numbers are rising, while others bring relief on specific medications.

  • Part D out-of-pocket cap and deductible: The annual cap on out-of-pocket spending for covered Part D drugs rises to $2,400 in 2027, up from $2,100 in 2026. The maximum Part D deductible also climbs from $615 to $700.
  • Part D subsidy and premium changes: A temporary Part D premium subsidy put in place earlier is winding down at the end of 2026, and enrollees who previously had zero-premium stand-alone Part D plans should check whether they'll owe a monthly premium starting in January 2027.
  • Part A and Part B baselines: According to CMS, the standard monthly Part B premium rises by $6.50 to $209.40 in 2027 (up from $202.90 in 2026), and the annual Part B deductible increases to $292. For Part A inpatient hospital care, the deductible rises by $40 to $1,776 per benefit period, with daily coinsurance of $444 for days 61 through 90 and $222 per day for skilled nursing facility days 21 through 100.
  • Medicare Advantage shifts: Projected average monthly Medicare Advantage premiums are dipping to $12.00 in 2027 from $14.37 in 2026, yet out-of-pocket limits, copays, deductibles, or extra benefits like dental and networks can still shift by plan and county.

Higher-income earners also face Income-Related Monthly Adjustment Amounts (IRMAA) on Part B and Part D in 2027. If your income dropped recently due to retirement, marriage, divorce, or the death of a spouse, you don't have to just accept an automatic surcharge without checking whether you can appeal using Form SSA-44 with the Social Security Administration.

How Negotiated Drug Prices Affect Your Bill in 2027

One of the most talked-about pieces of the 2027 rollout is the second wave of Medicare-negotiated prices under the Medicare Drug Price Negotiation Program. Fifteen high-cost drugs—including semaglutide medications (Ozempic, Rybelsus, Wegovy), Trelegy Ellipta, Xtandi, Pomalyst, Ofev, Ibrance, Linzess, Calquence, Austedo/Austedo XR, Breo Ellipta, Xifaxan, Vraylar, Tradjenta, Janumet/Janumet XR, and Otezla/Otezla XR—are slated for new maximum fair prices starting January 1, 2027.

CMS has projected that these negotiated prices could save people with Medicare roughly $685 million in out-of-pocket costs in 2027. At the same time, six drugs from the earlier negotiated group carry inflation-adjusted prices in 2027, while four drugs (Xarelto, Entresto, Stelara, and NovoLog/Fiasp) are removed from that negotiated list on January 1, 2027.

Here is what catches people off guard: a lower negotiated price at the program level doesn't automatically guarantee a tiny copay at the pharmacy counter. How much you pay depends on how your specific plan places the drug on its formulary, whether your cost share is a flat copay or percentage coinsurance, and whether rules like prior authorization or step therapy apply. Also, if you take a weight-loss medication strictly for weight loss rather than an approved medical indication like cardiovascular risk reduction or sleep apnea where covered, coverage rules can vary sharply by plan.

Original Medicare vs. Medicare Advantage When Rules Shift

Choosing between Original Medicare and Medicare Advantage isn't just a math problem; it's a trade-off between flexibility and bundled convenience. Original Medicare (Parts A and B) lets you see any doctor or hospital nationwide that accepts Medicare, generally without network referrals, though you usually pair it with a stand-alone Part D plan and often a Medigap policy to cover cost sharing—and Original Medicare doesn't have an annual out-of-pocket cap on Part A and Part B services.

Medicare Advantage (Part C) bundles Part A and Part B coverage, frequently includes Part D drug coverage and perks like routine vision, dental, or hearing, and sets an annual out-of-pocket maximum for covered Part A and Part B care ($9,850 in-network and $14,800 combined in- and out-of-network for 2027). The catch is network restrictions, prior authorizations, and year-to-year plan changes. If a plan leaves your area or drops your preferred specialist, you'll want to check your options carefully.

Also keep a practical rule in mind if you're thinking about switching from Medicare Advantage back to Original Medicare: getting a Medigap (Medicare Supplement) policy afterward can involve medical underwriting in many states, meaning health history could affect approval or pricing outside guaranteed-issue protections.

Practical Steps to Take Before December 7

Don't wait until December 6 to start digging through paperwork. Here is a straightforward way to handle this open enrollment season before the window closes:

  1. Read your Annual Notice of Change (ANOC): Check how your current plan's premiums, deductibles, drug tiers, networks, and extra benefits are changing for 2027.
  2. List every medication and dose: Write down your exact prescription names, dosages, quantities, and preferred pharmacy, then plug them into the official Medicare Plan Finder to compare estimated total 2027 costs across plans.
  3. Verify your doctors and hospitals: Confirm directly with your primary care doctor and specialists whether they are still in-network for any Medicare Advantage plan you're eyeing for 2027.
  4. Check extra help and payment spreading: If your income and assets are limited, look into Medicare's Extra Help program for drug costs, and if high upfront pharmacy bills strain your budget, check how the Medicare Prescription Payment Plan spreads out-of-pocket Part D costs across the year.
  5. Get free, unbiased help if you feel stuck: Reach out to your local State Health Insurance Assistance Program (SHIP) or call 1-800-MEDICARE so you're making a confident call before December 7.
NH

Naomi Hughes

A dedicated content strategist and editor, Naomi Hughes brings clarity and depth to complex topics. Committed to informing readers with accuracy and insight.